Ian Sollom MP: speeches

Ian Sollom MP: full overview

4 Jul 2025–3 Jul 2026

How these years work

Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.

Compare reporting years, sessions and IPSA financial years.

Parliamentary contributions: dates and coverage

Source checked
19 Nov 2026
Last successful import
19 Nov 2026
Records dated through
18 Nov 2026
Selected period
Reporting year 2: 4 Jul 2025 to 3 Jul 2026
Completeness
Published snapshot: 20,988 records in the source window 21 Aug 2026 to 19 Nov 2026. The published snapshot covers its stated source window. Older imports can extend beyond it; not every public speech is included.

How to read these datesOfficial source

This page lists the parliamentary spoken contributions we hold for Ian Sollom in the reporting year 2 (4 Jul 2025 to 3 Jul 2026). It does not include every public speech, party-conference address or constituency event. Latest retained contribution in this period: 3 Dec 2025. The source check date and dataset limits are shown above. Open the Hansard link for the full debate and surrounding context.

Clear speech filters

Read what this MP said, asked and contributed in Parliament.

2 published records · newest first.

Speeches

  • 3 Dec 2025 · Oxford to Cambridge Growth Corridor · Read the full contribution in Hansard
    More

    It is a pleasure to serve with you in the Chair, Sir Jeremy. I congratulate the hon. Member for Cambridge (Daniel Zeichner) on securing the debate. The Oxford-Cambridge growth corridor has had something of a tortured history. For nearly two decades, various iterations of the vision have promised transformational change, only to be shelved, rebranded or, as was reported in 2022, flushed down the toilet in mime by a previous Secretary of State, who is fortunately no longer here.

  • 11 Sep 2025 · Life Sciences Investment · Read the full contribution in Hansard
    More

    I welcome the Minister to his place. It is incredibly disappointing that MSD has pulled out of this billion-pound investment in the UK, including the loss of more than 100 jobs in important life sciences infrastructure. However, this has been on the cards for some time, and the warnings to Government have fallen on deaf ears. Earlier this year, AstraZeneca also cancelled planned upgrades to its production, and Novartis has described the UK as “largely uninvestable”.

Explore activity by topic or department

Contributions by debate topic

4 Jul 2025–3 Jul 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained.

View as listCommunities and local government: 15Communities and local government15Culture, media and sport: 9Culture, media and sport9Defence and foreign affairs: 8Defence and foreign affairs8Democracy and constitution: 11Democracy and constitution11Economy and business: 28Economy and business28Education and skills: 34Education and skills34Environment and energy: 2Environment and energy2Health and care: 9Health and care9Housing and planning: 3Housing and planning3Justice and policing: 6Justice and policing6Transport: 10Transport10Unclassified: 11Unclassified11
What this shows and doesn't show
4 Jul 2025–3 Jul 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained. Published records do not measure effort or effectiveness. Methodology.
Department or topicPublished records
Communities and local government15
Culture, media and sport9
Defence and foreign affairs8
Democracy and constitution11
Economy and business28
Education and skills34
Environment and energy2
Health and care9
Housing and planning3
Justice and policing6
Transport10
Unclassified11

Published records only — not a full account of an MP’s work. How we work →